L04AX08 darvadstrocel
ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 no longer supplied or not available
Active substance: Darvadstrocel – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L04 Immunosuppressants 545 medicines
- L04A Immunosuppressants 543 medicines
- L04AX Other immunosuppressants 206 medicines
- L04AX08 darvadstrocel 1 medicine
- L04AX Other immunosuppressants 206 medicines
- L04A Immunosuppressants 543 medicines
- L04 Immunosuppressants 545 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Alofisel 5 x 106 Cells/ml Dispersion for injection SPC no longer supplied | – |
Other groups of the same level
- L04AX01 azathioprine 10 medicines
- L04AX02 thalidomide 4 medicines
- L04AX03 methotrexate 38 medicines
- L04AX04 lenalidomide 100 medicines
- L04AX05 pirfenidone 14 medicines
- L04AX06 pomalidomide 10 medicines
- L04AX07 dimethyl fumarate 27 medicines
Other names of the ATC group
- German: L04AX08 Darvadstrocel
- Turkish: L04AX08 darvadstrocel
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L04AX08
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.